Bcl-2 belongs to a family ofapoptosis-regulatory proteins which incorporate into the outer mitochondrial as well as nuclear membranes. The mechanism by which the proto-oncogene product Bcl-2 inhibits apoptosis is thus far elusive. We and others have shown previously that the first biochemical alteration detectable in cells undergoing apoptosis, well before nuclear changes become manifest, is a collapse of the mitochondrial inner membrane potential (AXltm), suggesting the involvement ofmitochondrial products in the apoptotic cascade. Here we show that mitochondria contain a pre-formed ~50-kD protein which is released upon A~ m disruption and which, in a cell-free in vitro system, causes isolated nuclei to undergo apoptotic changes such as chromatin condensation and intemucleosomal DNA fragmentation. This apoptosis-inducing factor (AIF) is blocked by N-benzyloxycarbonyl-Val-Ala-Asp.fluoromethylketone (Z-VAD.fmk), an antagonist of interleukin-1]3-converting enzyme (ICE)-like proteases that is also an efficient inhibitor of apoptosis in cells. We have tested the effect of Bcl-2 on the formation, release, and action of AIF. When preventing mitochondrial permeability transition (which accounts for the pre-apoptotic A~ m disruption in cells), Bcl-2 hyperexpressed in the outer mitochondrial membrane also impedes the release of AIF from isolated mitochondria in vitro. In contrast, Bcl-2 does not affect the formation of AIF, which is contained in comparable quantities in control mitochondria and in mitochondria from Bcl-2-hyperexpressing cells. Furthermore, the presence of Bcl-2 in the nuclear membrane does not interfere with the action of AIF on the nucleus, nor does Bcl-2 hyperexpression protect cells against AIF. It thus appears that Bcl-2 prevents apoptosis by favoring the retention of an apoptogenic protease in mitochondria.
B
efore cells manifest nuclear signs ofapoptosis, they disrupt the mitochondrial transmembrane potential (ARtm) 1. This pre-apoptotic AXI*,,~ collapse occurs in nu~Abbreviations used in this paper: Ac-DEVD.CHO, acetyl-Asp-Glu-ValAsp-aldehyde; Ac-YVAD.CHO; acetyl-Tyr-Val-Ala-Asp-aldehyde; Ac-YVAD.cmk, aceyl-Tyr-Val-Ala-Asp-chloromethylketone; AIF, apoptosisinducing factor; Atr, atractyloside; CMXP,.os, chloromethyl-X-rosamine; Axlt,,,, mitochondrial transmembrane potential; mC1CCP, carbonylcyanide m-chlorophenylhydrazone; Neo, neomycin resistance gene; MDH, malate dehydrogenase; MAO, monoamine oxidase; PI, propidium iodine; PT, pemleability transition; P, OS, reactive oxygen species; SDH, succihate dehydrogenase; t-BHP, ter-butylhydroperoxide; TLCK, N-tosylt-lysyl chloromethylketone; TPCK, N-tosyl-l-Phe-chloromethylketone; PARP, poly (ADP-ribose) polymerase; Z-D.CH2-dcb, N-benzyloxycarbonyl-Asp-CH20C(O)-2-6,-dichlorobenzene; Z-FA.fmk, N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone; Z-VAD.fmk, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone. S.A. Susin and N. Zamnzami contributed equally to this paper. merous cell types (neurons, fibroblasts, myelomonocytic cells, lymphocytes, hepatocytes), irrespective of the apoptosis inducer or the presence of mitochondrial DNA (1-5 and references cited therein). As to the mechanism of the pre-apoptotic A~ m disruption, it appears that it is mediated by so-called "permeability transition (PT) pores", i.e., regulated megachannels that allow for the dissipation of inner transmembrane ion gradients. Thus, a series of drugs known for their PT-inhibitory potential (6, 7) such as cyclosporin A (which acts as a transient inhibitor of PT, via mitochondrial cyclophilin) or bongkrekic acid (which acts as a stable inhibitor of PT, via specific binding to the inner membrane adenine nucleotide translocator) inhibit the preapoptotic A~ m collapse (2, 4) . Bonkrekic acid is also an efficient inhibitor of other manifestations of apoptosis at the levels of the nucleus (chromatin condensation and DNA fragmentation), of the cytoplasma (depletion of non-oxidized glutathione and hyperproduction of reactive oxygen species), and of the plasma membrane (exposure of phosphatidylserine residues in the outer membrane leaflet, increase in permeability) (4, 8) . Altogether these findings suggest that mitochondrial PT may be an important c o m m o n event of the effector phase of the apoptotic process. This idea is underlined by the observation that mitochondria undergoing PT acquire the capacity to induce nuclear apoptosis in an in vitro system (4) . A further argument in favor of the implication of PT in apoptosis regulation is the finding that the apoptosis-inhibitory proto-oncogene product Bcl-2 functions as an endogenous PT inhibitor. This PTprotective Bcl-2 effect has been observed in the overall context of the intact cell (2) , as well as in isolated mitochondria (4) , suggesting that PT may indeed constitute the (or one of the) Bcl-2-regulated checkpoint(s) of the apoptotic cascade. It has remained obscure, however, how the putative B c l -2 / P T checkpoint could be related to another apoptosis checkpoint controlled by a cascade of proteases belonging to the expanding I C E / C P P 3 2 / C e d -3 family (9) (10) (11) , especially in view of the fact that Bcl-2 can regulate the activation of at least some of these proteases (12) .
Based on the findings of other investigators (13) (14) (15) (16) (17) , we have recently developed a cell-free system ofapoptosis. Using such a system, we observed that isolated mitochondria induced to undergo PT in vitro release a heat-labile > 1 0 -kD factor capable of inducing isolated nuclei to rapidly (~<15 rain) manifest apoptotic changes such as chromatin condensation and oligonucleosomal D N A fragmentation (4) . This finding suggested a direct molecular link between pre-apoptotic Axlt,, disruption and nuclear apoptosis. In the present paper, we report the biochemical characterization of the apoptogenic factor released by mitochondria. Intriguingly, this factor possesses a protease activity which is neutralized by a degenerate tripeptide inhibitor of ICE-like proteases, suggesting a direct relationship between PT and protease activation during the effector phase of apoptosis. In addition, we characterized the effect of Bcl-2 on the production, release, and action of this mitochondrial apoptosis-inducing factor (Alia). Our data indicate that Bcl-2 solely interferes with the PT-dependent release of AIF, yet does not neutralize its lethal action. These data may provide major clues for the understanding of apoptosis regulation.
Materials and Methods
Orga~lsand Cell Lim's. Livers were obtained from female Balb/c mice (6-8 wk of age) subjected to perfusion of the portal vein with isotonic PBS (pH 7.2; 5 ml at room temperature). 2B4.11 T cell hybridoma cell lines stably transfected with an SFFV.neo vector containing the human bcl-2 gene or the neomycin (Neo) resistance gene only were kindly provided by Jonathan Ashwell (National Institutes of Health, Bethesda, MD). In this cell line, Bcl-2 overexpression confers resistance to most but not all apoptosis-inducing stimuli (18 Pmjfication of Orcanelles. Mitochondria were purified on a Percoll | (Pharmacia, Uppsala, Sweden) gradient (19) and were stored on ice in B buffer (400 mM mannitol; 10 mM KH2PO4, 5 mg/ml BSA, 50 mM TRIS-HC1, pH 7,2) for up to 4 h. Mitochondria were washed and resuspended in cell-free system (CFS) buffer (220 mM mannitol; 68 mM sucrose, 2 mM NaC1, 2.5 mM PO4H2K, 0.5 mM EGTA, 2 mM MgCI> 5 mM pyruvate, 0.1 mM phenylmethyl sulfonylfluoride [PMSF], 1 mM dithiotreitol, 10 mM Hepes-NaOH, pH 7.4) before manipulation (4). Submitochondrial fractions were obtained as described (20) . Osmotic shock of mitochondria leading to the disruption of the outer but not of the inner membrane or digitonin lysis (1.2%) of the outer mitochondrial membrane for the obtention of intermembrane proteins was performed according to standard methods (20). The four mitochondrial compartments (inner + outer membrane, intermembrane, matrix) were identified by the specific activities of the marker enzymes monoamine oxidase (MAO) for the outer membrane, succinate dehydrogenase (SDH) for the inner me:nbrahe, and malate dehydrogenase (MDH) for the matrix (21) . Enzyme activities were determined as described (21) and expressed as specific activities (nmol of transformed substrate • n:g-I total protein X rain-I). Freeze-thawing of intact mitochondria was performed in two cycles (liquid nitrogen followed by 37~ during 5 min). Ultrasonication was carried out using a Branson sonicator (model 130; Danbury, CT; 20 kHz, 400 W, 5 n:in, 4~ In one experiment, the AIF-containing intermembrane fraction was treated by proteinase K digestion (100 ixg/lnl, 10 min at 37~ Boehringer Mannheim, Mannheim, Germany), followed by proteinase K inactivation by addition of / m M PMSF (22) . Nuclei from the indicated cell type were purified on a sucrose gradient and conserved in 50% glycerol (Sign:a) in HNB buffer, at 20~ for a maxinmm of 15 d, as described (13, 23) . The expression of Bcl-2 on the surface of isolated nutochondria or nuclei was determined using an FITC-labeled hBcl-2-specific antibody (1 Ixg/ml, 30 rain at 4~ clone 124; 1)AKO, Glostrud. Denmark).
Determination ~f Apwtogenic Effects on Isolated Nuclei. For the standard assessment ofchromatin condensation, nuclei from HeLa cells were purified on a sucrose gradient as above, washed 2• (1,000 ,G 10 rain, 4~ and resuspended m CFS buffer. In standard conditions, nuclei (103 nuclei/bLl ) were cultured in the presence of mitochondrial preparations for 90 rain at 37~ Nuclei were stained with 4'-6-diamidino-2-phenylindole dihydrochloride (DAPI; 10 txM; Molecular Probes, Leiden, The Netherlands) and examined by fluorescence microscopy (13, 14) . A minimun: of 200 events were scored and nuclei presenting chromatin conden-sation and/or a translucid aspect were interpreted as being apoptotic (4). Alternatively, nuclei were stained with propidium iodide (PI; 10 Izg/ml; Sigma and the lipophilic dye 5-methyl-bodipy-3-dodecanoic acid (100 riM; Molecular Probes), followed by cytofluorometric analysis in a EPICS Profile II Analyzer (Coulter, Hialeh, FL). Only membrane-surrounded (5-methyl-bodipy-3-dodecanoic acid-labeled) particles were gated on. A good correlation between the frequency of nuclei exhibiting chromatin condensation with DAPI and hypoploidy with PI was obtained (S.A. Susin and G. Kroemer, manuscript in preparation). In one series of experiments, nuclei from Neo-or Bcl-2-transfected T cell hybridoma cells were subjected to transmission electron microscopy, as described (8) . Furthermore, in one experiment, nuclei were pretreated with Z-VAD.fmk (1 mM, 60 min, 37~ in CFS buffer), washed 3• (1000 g; 10 rain), and exposed to mitochondrial factors.
Purification q[ the Mitochondrial Apoptosis-inducing Factor (AIF).
Purified hepatocyte mitochondria were treated with atractyloside (5 mM; Atr; Sigma) to induce PT and liberation of AIF (4). Supernatants (150,000 g; 1 h; 4~ from these mitochondria were concentrated on Centricon 10 membranes (i>10 kD; Amicon Inc., Beverly, MA), which retains the entire AIF activity (4), and then subjected to a Pharmacia MonoQ (HR5/5) FLPC column pre-equilibrated with protein-free CFS buffer. Elution was performed on a linear gradient from 0 to 250 mM NaC1 at 0.5 ml/ min over 30 rain, followed by elution at 1 M from min 33. After dialysis (10 kD membrane) in CFS buffer, all fractions were subjected to the assessment ofpro-apoptotic activity. The active fraction (eluting at 110 mM NaC1) was dialyzed against protein-free CFS buffer (4~ 4 h, 5,000• excess of CFS buffer) and subjected to re-injection into the Phamlacia MonoQ FLPC column (5 Ltg; elution as described above).or a reverse phase C-18 column coupled to a Hewlett Packard 1090 HPLC apparatus (eluted on a linear gradient from 0.1% trifluoracetic acid.in water to 0.1% trifluoracetic acid.in acetronitrile at I ml/min over 30 min). The SDS-PAGE (12%; performed in reducing conditions: 1 mM dithiotreitol) of AIF purified by anion exchange chromatography (concentrated on a Centricon 10 membrane; 2 >g) was subjected to Silver staining (BioRad, Hercules, CA). Alternatively, AIFcontaining supernatants or AIF purified on the MonoQ column were fractionated on a Pharmacia Superdex75 column equilibrated with CFS buffer. All fractionation steps had to be carried out at 4~ to avoid loss of biological AIF activity. To determine the inhibitory profile of AIF, different protease inhibitors were added to purified AIF or AIF-containing preparations: Z-VAD.fmk; N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone (Z-FA.fink; Enzyme Systems), N-tosyl-t-Lys-chloromethylketone (TLCK; SiNna), N-tosyl-r-Phe-chloromethylketone (TPCK), E64, leupeptin, p-chloromercuryphenylsulfonic acid, N-phenylmaleimide (Sigma), calpain inhibitors I and II (Boehringer), or modified tetrapeptides and N-benzyloxycarbonyl-Asp-CH2OC(O)-2-6,-dichlorobenzene (Z-D.CH2-dcb; Bachem).
Quantitation of Mitodlondrial Permeability Transition (PT).
For the induction of PT, mitochondria from different cell lines were incubated with the indicated doses of Atr, t-BHP or mC1CCP (4). The A~n, was measured using the A~ncsensitive cationic lipophilic dye chloromethyl-X-rosamine (CMXRos; 10 nM; 15 min at 37~ Molecular Probes) (5), after having added the indicated PT inducer (15 rain, 37~
Mitochondria were analyzed in an Elite cytofluorometer (Coulter). All A~,~ determinations were performed at least three times in each experiment.
Determinations of Protease and DNAse Aaivity. AIF-mediated cleavage of nuclear substrates is indicated by the comparative analysis of Coomassie-stained SDS-PAGE of HeLa nuclei (5 • 106/lane) cultured in the presence or absence of 100 ng/ml purified AIF (90 min, 37~ The degree ofpoly(ADP-ribose) polymerase (PAl<P) and lamin cleavage was determined by immunoblots, using the monoclonal antibodies C2-10 (purchased from Guy Poirier, Montreal University, Canada) and E6 (kind gift from Dr. E. Nigg, Lausanne University, Lausanne, Switzerland), respectively (14, 24, 25) . Positive controls were human T lymphoma cells exposed to anti-Fas antibody (500 ng/ml; 4 h; Immunotech, Marseille, France). Endonuclease activity was determined on supercoiled pUC DNA (500 ng in CFS buffer; 120 min; 37~ followed by ethidium bromide agarose gel (1%) electrophoresis.
Results
Localization and Purification of AIF. Supernatants from mitochondria that have undergone PT but not those from control mitochondria induce signs of apoptosis such as nuclear chromatin condensation in a cell free system (4). Thus, mitochondria treated with the PT inducers atractyloside (Atr, a specific ligand of the adenine nucleotide translocatot), m C I C C P (a protonophore) and t-BHP (a prooxidant) release an apoptogenic activity into the supernatant that we have baptized "apoptosis-inducing factor" (AIF) (Fig. 1 ). In addition to these PT-inducing treatments, destruction ofmitochondrial membranes via sonication, osmotic shock, or digitonin treatment (which specifically lyses the outer but not the inner membrane, yielding the intermembrane fraction o f proteins) (20) also releases AIF, indicating that AIF is pre-fomled. Whereas, the fraction o f soluble intermembrane products does contain AIF activity, neither purified mitochondrial membranes nor the soluble products of the mitochondrial matrix are apoptogenic (Fig. 1 , Table 1 ). Thus, AIF is not found in submitochondrial fractions that contain high specific activities o f marker enzymes for the outer membrane (MAO), inner membrane (SDH), and matrix (MDH) ( Table 1) . Proteinase K treatment ofintermembrane proteins destroys AIF activity, indicating that AIF is a protein (Fig. 1) . Ion exchange chromatography yields only one AIF activity which elutes at 110 m M NaC1 (Fig. 2 A) . The AIF-containing fraction purified on an anion exchange column contains only one major protein as determined by four different methods: reinjection into the same anion exchange FPLC column (Fig. 2 B) , analysis on a reverse phase H P L C column (which separates proteins based on their hydrophobicity; Fig. 2 C) , separation in a molecular sieve FPLC column (Fig. 2 D) and SDS-PAGE revealed by the sensitive silver staining technique (Fig. 2 E) . Thus, anion exchange chromatography (Fig. 2 A) , molecular sieve chromatography (Fig. 2 D) , and SDS-PAGE (Fig.  2 E) identify hepatocyte AIF as a single ~5 0 -k D protein with an estimated isoelectric point of 5.5. AIF purified on an anion exchange column (Fig. 2 A) is homogenous with regard to charge (Fig. 2 B) , hydrophobicity (Fig. 2 C) , and apparent molecular weight in both denaturing and nondenaturing conditions (Fig. 2, D and E) . AIF is low-abundant (<0.1% of mitocbondrial proteins) and labile at room temperature, requiring purification at 4~ AIF activity is inducing factor (AIF). Isolated HeLa nuclei were cultured in the presence of various preparations of mouse hepatocyte mitochondria: ultracentrifuged supematants of mitochondria (10 mg protein/ml) treated with Atr (5 raM), mC1CCP (100 p.M), t-BHP (50 IxM), osmotic shock, or ukrasonication; soluble products (200 p.g protein/roll of the mitochondrial matrix, purified inner and outer mitochondrial membranes, or soluble factors of the intem~embrane space. After 90 rain of culture at 37~ the frequency of nuclei exhibiting chromatin condensation was assessed by labeling with DAPI. Proteinase K digestion ofintennembrane proteins was followed by addition of 1 mM PMSF for its inactivation, as described in Materials and Methods. P, epresentative DAPl-stained HeLa nuclei (>70 % of the phenotype) cultured in the presence of untreated or proteinase K-inactivated intermembrane preparation are shown. In synthesis, it appears that AIF is o n e pre-fom~ed, soluble m i t o c h o n d r i a l i n t e r m e m b r a n e protein. Submitochondrial fractions were purified as described in Materials and Methods. Marker enzymes were measured using colorimetric approaches on synthetic substrates. AIF activity was determined for each fraction (200 Ixg protein/ml) as in Fig. 1 . Results are mean values +-SD of four independent experiments.
AIF Possesses a Proteolytic Activity That Is Inhibited by Z-VAD:fmk.
( Fig. 3 A a n d data n o t s h o w n ) . A l t o g e t h e r t h e s e data suggest that A I F possesses a c y s t e i n e -d e p e n d e n t 
fmk). (B) Inhibition of the AIF activity contained in supernatants from
Atr-treated mitochondria. Nuclei were treated at the same time with such supernatants and/or 100 txM Z-VAD.fmk. Alternatively, the supernatant was pretreated with Z-VAD.fmk (100 • ~M; 30 rain, 37~ followed by dialysis (4~ 4 h, 5,000• excess of CFS buffer) for removal-of Z-VAD.fmk and testing for apoptotic activity on isolated HeLa nuclei. Furthermore, nuclei were pretreated with Z-VAD.fmk (1 raM, 60 min, 37~ in CFS buffer), washed 3• and exposed to the untreated AIF-containing supernatant, (C) Z-VAD.fmk-mediated inhibition of AIF-induced chromatinolysis. Nuclei were treated with CFS buffer only (control), purified AIF (100 ng/ nil), or AIF pretreated with Z-VAD.fmk and dialysis. Alternatively, nuclei were first treated with Z-VAD.fmk, then washed and cultured with AIF. Nuclei were stained with PI, as detailed in Materials and Methods, followed by cytofluorometric analysis, Percentages refer to the subdiploid population. (D) Z-VAI).fmk-mediated inhibition of AIF-induced DNA fragmentation. Isolated nuclei (1 • 10 ~' ) were cultured during 90 min in the presence of purified AIF (100 ng/ml, lanes 3 and 4) and/or Z-VAD.fmk (100 btM, lanes 2 and 4) and analyzed by ethidium bromide agarose gel electrophoresis. (E) Effect of AIF on protease substrates and purified DNA. HeLa nuclei were exposed to CFS buffer only (1), the supernatant of digitonin-permeabilized mitochondria (2), or 100 ng/ml purified AIF (3). The degree of PARP and lamin cleavage was detemlined by immunoblots. Positive controls (co) are human lymphoma cells exposed to anti-Fas antibody. The same three preparations were tested for endonuclease activity on pUC DNA, followed by ethidium bromide agarose gel electrophoresis. catalytic activity not identical with but related to ICE and CPP32. Z -V A D . f m k prevents the chromatin condensation induced by purified AIF as well as by supernatants from Atr-treated mitochondria (Fig. 3, B and C) , in accord with the observation that AIF seems the only pro-apoptotic mitochondrial factor (Fig. 2 , A and C; see above). Z -V A D . f m k is an irreversible rather than competitive protease inhibitor (26) (27) (28) . Accordingly, pre-incubation o f AIF with Z -V A D . f m k causes a durable AIF inactivation that persists after removal o f Z -V A D . f m k (Fig. 3, B and C) . In contrast, pre-incubation of nuclei with Z -V A D . f m k has no significant protective effect against AIF (Fig. 3 , B and C), thus confirming that Z -V A D . f m k acts on AIF rather than on the nuclear target(s) of AIF. Z -V A D . f m k prevents all manifestations o f apoptosis induced by AIF: chromatin condensation (Fig. 3, A and B) , D N A loss from nuclei (Fig.  3 C) and oligonucleosomal D N A fragmentation (Fig. 3 D) .
50-lO, [ ] mCICCP (40 pM) [ ] t-BEIP (50 gM) [E] ceramide ($
Mitochondria contain an endonuclease which has also been found in nuclei from thymocytes (29) . Accordingly, a D N A s e activity is found in the supernatant of digitonintreated mitochondria (Fig. 3 E) . However, purified AIF has no intrinsic D N A s e activity (Fig. 3 E) , indicating that it probably induces D N A fragmentation via activating preexisting nuclear DNAses. Although AIF has a proteolytic activity on unidentified nuclear substrates of approximately 28, 42, and 90 kD (not shown), it fails to cleave P A R P or lamin in isolated nuclei (Fig. 3 E) . Thus, the nuclear substrate(s) of AIF must be different from those cleaved by p r o m i n e n t members of the I C E / C P P 3 2 family ofproteases (11, 25, 30) .
If AIF was a rate-limiting factor of cell death, its inhibition should retard or inhibit nuclear apoptosis in cells. According to the literature, the AIF inhibitor Z -V A D . f m k prevents apoptosis of mammalian and insect cells responding to a variety of different lethal stimuli (26) (27) (28) . In addition, as shown in Fig. 4 , Z -V A D . f m k (but not its structural analogue A c -Y V A D . c m k , a specific inhibitor o f ICE) inhibits apoptosis induced by ceramide, the pro-oxidant t-BHP, or the protonophore mC1CCP, which acts directly on the inner mitochondrial m e m b r a n e (Fig. 5 ). This effect is o btained at similar doses as those required to inactivate purified AIF ('--'60 I~M) in vitro (Fig. 3 A) , underlining the probable role of AIF in apoptosis.
In synthesis, it appears that mitochondria u n d e r g o i n g P T (6), diluted to a concentration of 10 mg/ml protein in CFS buffer, and treated during 5 min at 37~ with Atr (5 mM), t-BHP (50 btM), or mCICCP (5(1 IxM). Alternatively, lnitochondria from neo-or bcl-2-transfected cells were exposed to osmotic shock, ultrasonication, or the detergent digitonin, followed by centrifugation. Supematants were tested for apoptosis induction in isolated HeLa nuclei, as in Fig. 1 . The inset shows cytofluorometric profiles of purified mitochondria stained with an FITC-labeled hBcl-2-specific antibody. (C) DNA-degrading activity ofsupernatants from control and Bcl-2 mitochondria. Supernatants were generated from control nfitochondria (I, 3) or Bcl-2-hyperexpressing mitochondria (2, 4) exposed to Atr (1, 2) or osmotic shock (3, 4) as in B and were tested for induction of 1)NA degradation on isolated Hela cells as in Fig. 3 D. release a Z-VAD.fmk-inhibitable protease which is sufficient and probably necessary to cause nuclear apoptosis.
Bcl-2 Prevents the Permeability Transition-dependent Release ofAIFfrom kqitochondria.
Bcl-2 belongs to a family of apoptosis-regulatory proteins which incorporate into the outer mitochondrial membrane (31) (32) (33) (34) . Since the antiapoptotic mode of action of Bcl-2 is elusive, we addressed the question as to whether Bcl-2 inhibits apoptosis via interfer-ing with the formation or the release o f A I F . Transfectionenforced hyperexpression of Bcl-2 prevents the induction o f apoptosis by t-BHP and the mitochondrion-targeted agent mC1CCP (reference 4 and Fig. 4 ). In addition, isolated mitochondria from bcl-2 transfected cells (which hyperexpress Bcl-2, see insert of Fig. 5 B) fail to disrupt their Axlr,, 1 in response to Atr, the pro-oxidant t-BHP, and a low dose (10 btM) of the protonophore mC1CCP (Fig. 5 A) , thus confirming our previous observations according to which Bcl-2 prevents the PT-dependent colloidosmotic swelling of mitochondria in vitro (4). Simultaneously, Bcl-2 overexpressing mitochondria fail to release AIF activity in response to these PT inducers (Fig. 5, B and C) , underscoring the absolute correlation between PT and AIF release that we have previously reported (4) . Thus, AIF is present in the supernatants of control mitochondria treated with Atr, t-BHP, or mC1CCP, yet is absent or greatly reduced in the supernatant of Bcl-2 hyperexpressing mitochondria treated with these reagents. In contrast, lysis of control and Bcl-2-overexpressing mitochondria with detergents or osmotic shock releases equal amounts of AIF activity (Fig. 5 , B and C).
Thus, Bcl-2 inhibits the mitochondrial AIF release in response to determined stimuli but not the formation of AIF.
Failure of Bcl-2 to Interfere with AIF Action on Nuclei and
Cells. The Bcl-2 p26 protein possesses a transmembrane domain allowing for its incorporation into different intracellular membranes, including the outer mitochondrial membrane, the endoplasmatic reticulum, and the nuclear envelope (33, 34) . W e therefore addressed the possibility that Bcl-2 might antagonize the action of AIF. In a first series of experiments, nuclei were purified from control (Neo) and Bcl-2 transfected cells and cultured with purified AIF. Bcl-2 expressing nuclei (Fig. 6 A, inse 0 undergo apoptotic changes in response to AIF, exactly as this is the case for control nuclei (Fig. 6, A and B) . Electron microscopic analysis confirmed that Bcl-2 hyperexpression does not affect the action of AIF. Both control and Bcl-2-overexpressing nuclei manifest the same pattern of chromatin condensation (Fig. 6 C) . Thus, nuclear expression of Bcl-2 does not affect the action of AIF.
Since Bcl-2 exists also in localizations outside of the nuclear and mitochondrial membrane (33), we decided to evaluate the effect ofBcl-2 overexpression on cells exposed to AIF. As shown above, AIF is a hydrophilic protein and thus does not permeate the plasma membrane. Accordingly, AIF only induces apoptotic changes in permeabilized cells (Fig. 7) . Introduction of AIF into saponin-treated ceils causes the same extent of DNA fragmentation in control and in Bcl-2-hyperexpressing cells (Fig. 7) . Thus, Bcl-2 only acts upstream, at the level of AIF release, and has no detectable effect on AIF action, both in cells and in isolated nuclei.
Discussion
In this paper, we provide several new elements allowing for the construction of a scenario recreating the apoptotic ellector phase and its regulation by the proto-oncogene bcl-2.
AIF, a Mitochondrial Apoptogenic Protease. Mitochondria undergoing PT release a protein factor, AIF, which appears to be a pre-formed, ubiquitous factor associated with the intermembrane space (Fig. 1) . AIF suffices to induce typical manifestations of nuclear apoptosis in a cell-free, cytosolfree system: chromatin condensation, chromatinolysis, hypoploidy, and oligonucleosomal ladder-type DNA fragmentation (Fig.s 1, 3 , and 6 C). AIF lacks an intrinsic DNAse activity, yet seems capable of activating pre-formed nuclear DNAses. Intriguingly enough, all in vitro activities of AIF are blocked by Z-VAD.fmk (Fig. 3) , which is also an efficient inhibitor of apoptosis in mammalian and insect cells (26-28 and Fig. 4 ). Although this is not a formal proof, this finding underlines the probable importance of AIF as a rate-limiting factor of the apoptotic process in vivo. Z-VAD.fmk has been designed for the inhibition of ICE-like proteases. However, AIF is not among the known members of the family of ICE/CPP32/Ced3-1ike proteases. Its molecular mass (~50 kD), subcellular localization, and proteolytic spectrum (notably the absence of PARP cleavage) are not compatible with those of known members of the ICE/CPP32/Ced3 family (11) . In addition, preliminary NH2-terminal sequence data suggest that at least mouse hepatocyte AIF is encoded by a novel gene. Thus, it would be premature to consider AIF as an ICElike protease, and the further characterization of AIF will require its cloning and genetic manipulation.
Is AIF the Principal Apoptogenic Factor? Our data suggesting a major role of AIF in the apoptotic process are compatible with previous reports that mitochondria are necessary to mediate apoptosis either in mammalian or in Xenopus laevis cells (15, 16) and that some known members of the ICE family such as ICE itself or CPP32 do not suffice to cause apoptosis in a cell-free system (14, 17, 30, 35) . Moreover, our data are compatible with reported cell-free systems of apoptosis with regard to the particular ion requirements of AIF action, which functions in the presence of calcium chelators and at a neutral pH (13) (14) (15) (16) (17) . In contrast, our results appear to be in conflict with the observation that mitochondria can be substituted for by ceramide to induce nuclear apoptosis in vitro (16) . However, careful analysis reveals a major functional difference between AIF and ceramide. First, the apoptosis-inducing effect of ceralnide on cells is antagonized by Bcl-2 (2), which is not the case for AIF (Fig. 7) . Second, maximal doses of C2 ceramide require a minimum of 3 h to induce nuclear apoptosis in vitro (16) , whereas high doses of AIF act within ~15 rain (4). Thus, AIF rather than ceramide would be a rate-limiting apoptogenic factor. Nagata and co-workers have reported the existence of a cytosolic apoptogenic factor that is produced upon Pas-cross-linking (17, 35) . The method of isolation to obtain this factor, repeated freezing and thawing, would destroy the activity of AIF. Interestingly, these authors have found that cytosolic extracts treated with recombinant CPP32 become apoptogenic (35) . As a consequence, it cannot be excluded that, at least in Fasinduced apoptosis, other factors than AIF may be involved in the mediation of nuclear apoptosis. Further exploration of these poorly characterized in vitro systems will have to resolve this issue. As mentioned above, AIF fails to cleave nuclear PARP. Since the knock-out of the PARP gene has no major effects on apoptosis regulation, cleavage of this substrate is likely to constitute a consequence rather than a mechanism ofapoptosis (36) . However, since proteolysis of PARP is a common sign of nuclear apoptosis in cells (37) and in some cell-free systems of apoptosis (14, 25) , additional (AIF-activated?) cytosolic proteases appear to be involved in the apoptotic degradation phase.
Mode of Action of Bcl-2. To unravel the relationship between AIF and Bcl-2, we have investigated three mutually non-exclusive possibilities. Bcl-2 might suppress (a) AIF synthesis; (b) AIF release; (c) or AIF action. Out data clearly indicate that Bcl-2-overexpressing mitochondria contain normal amounts of pre-formed AIF (Fig. 5, B and C) , an observation that would be compatible with an eventual house-keeping function of this ubiquitous protein. Instead of preventing AIF formation (Fig. 5, B and C) or action (Figs. 6 and 7), Bcl-2 inhibits the PT-mediated release of AIF (Fig. 5, B and C). Our data suggest that Bcl-2 is primarily an inhibitor of PT (reference 4 and Fig. 5 A) , in line with the facts that it is mainly situated in the inner-outer mitochondrial membrane contact sites (33, 34, 38) (where PT pores form [6] ) and that its expression level correlates stoichiometrically with one of the putative PT pore constituents, the peripheral benzodiazepine receptor (39) . Exploration of the mechanisms how Bcl-2 regulates PT-dependent AIF release will require further characterization of the PT pore complex.
In conclusion, Bcl-2 suppresses apoptotic PT and AIF release from mitochondria, yet does not interfere with the formation or action of AIF. This interpretation is in accord with previous genetic (40) (41) (42) (43) and functional data (15, 43, 44) , suggesting that, at least in some experimental systems, the mitochondrial but not the nuclear localization of Bcl-2 would determine its anti-apoptotic capacity. These results are also compatible with the absent or marginal apoptosis- The scheme provides an overview over the temporal and mechanistic advancement of the apoptotic process. Distinct apoptosis inducing pathways activated dunng the stimulus-dependent initiation phase of apoptosis converge at the level of the mitochondrion to induce pemleability transition (PT), which is subjected to regulation by Bcl-2 and Bcl-2 homologues. PT and/or associated release of AIF triggers a number of functionally independent events: hypergeneration of reactive oxygen species, a number of cytoplasnfic changes, nuclear apoptosis and apoptotic alterations of membrane structure. These latter are among the first consequences of PT, thus allowing for the heterophagic elinfination of apoptotic cells by adjacent cells, before fullblown apoptosis occurs. At present it remains unknown which post-PT events are coordinated by AIF and whether AIF directly or indirectly engages in a self-amplifying PT-inducing feedback loop.
inhibitory effect of Bcl-2 on cell-free systems, when Bcl-2 protein is added to cytoplasma extracts already containing soluble pro-apoptotic factors (15, 16) .
Hierarchy between Bcl-2-and Protease-controlled Check Points of the Apoptotic
Cascade. The present data may resolve a long-lasting controversy on the hierarchy between the putative control points of apoptosis regulated by Bcl-2/Ced-9 and ICE/Ced-3-1ike proteases, respectively (9-12, 31, 32) . According to our data, Bcl-2 Would prevent apoptosis by maintaining the subcellular compartmentalization of AIF, thereby suggesting a scenario that de facto abolishes the existence of such a hierarchy, at least at the level of the mitochondrial protease. However, it would be an oversimplification to assume that all proteases of the ICE/CPP32/Ced-3 family control the same point of the apoptotic cascade. Thus, ICE itself clearly acts upstream of the PT check point, in the sense that ICE activation triggered by Fas is an extremely rapid (< 15-30 rain) event (35) that precedes the PT-mediated A~n, collapse. Inhibition of ICE by Ac-YVAD.cmk prevents the A~,,, disruption induced by Fas cross-linking (5). Moreover, recombinant ICE is a direct inducer of PT in isolated mitochondria (M. Castedo, S.A. Susin and G. Kroemer, manuscript in preparation). The protease inhibitors T L C K and Z-VAD.fmk can also prevent the glucocorticoid-triggered A~,n disruption in thymocytes (8) , suggesting the implication of one or several Z-VAD.fmk-inhibitable proteases in the induction of PT. W h e n combined with the facts reported in this paper, this observation can be interpreted in two different ways. As a first possibility, one type of Z-VAD.fmk-inhibitable protease(s) would act upstream and another one, AIF, downstream of the mitochondrion. As a second possibility, AIF (and AIF-activated proteases) might engage in a self-amplification loop in which an initial triggering of PT causes AIF release, which in turn favors PT. These scenarios are currently under active investigation.
A Speculative Model of Apoptosis Regulation and Execution.
Current models ofapoptosis subdivide the c o m m o n pathway into an initial effector phase, during which the "decision to die" is still subject to regulatory mechanisms, and a later degradation phase, beyond the "point-of-no-return", during which the progressive augmentation of entropy due to the activation of catabolic enzymes precludes further regulation (3). Collectively, our data can be embedded into the following working hypothesis (Fig, 8) . Different pathways of apoptosis induction (some of which may involve R O S production, ICE activation, changes in the expression level of Bcl-2/Bax etc.) converge at the level of the mitochondfion to induce PT and an associated A q~ collapse. This event is controlled by Bcl-2 and probably by other Bcl-2 homologues located in the outer mitochondrial membrane. As a result of PT, which marks the point-of-no-return, the cell manifests multiple alterations: perturbation of the plasma membrane structure, increased production and action of superoxide anion, cytoplasmic changes, and nuclear apoptosis (2, 4, 8) . At least some of these consequences of PT are dissociable among each other. Thus, the exposure of phosphatidylserine residues on the outer plasma membrane leaflet precedes hyperproduction of superoxide anions and does not require the presence of a nucleus (5); and nuclear apoptosis can be observed in P, OS-free conditions (45) . Hence, it appears that these manifestations of the degradation phase of apoptosis are not linked among each other via direct cause-effect relationships and are rather coordinated by a superior control event (8) . Future investigations will have to determine to which extent the metabolic consequences of PT such as uncoupling of the respiratory chain or the PT-dependent AIF release function as coordinators of the apoptotic cascade.
In synthesis, the available data provide a plausible explanation for, as well as a number of testable hypotheses on the regulation of the apoptotic effector phase by proteases, mitochondria, and proto-oncogenes of the Bcl-2 family. The progressive unmasking of the mechanism of action of Bcl-2, one of the major endogenous survival factors of lymphoid cells and one of the clinically most important oncoproteins, may have f:ar-reaching consequences for the rational design of apoptosis-modulatory drugs.
